NCT05823948 - A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

March 6, 2024

Study Completion Date

April 11, 2024

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Icodec

Participants will receive insulin icodec once-weekly subcutaneously into the thigh, upper arm or abdomen.

Trial Locations (9)

Accellacare_NC, Wilmington

Diabetes & Endocrinology Asso, Canton

International Diabetes Center, Minneapolis

Velocity Clin Res, Dallas, Dallas

Northeast Clinical Research of San Antonio, San Antonio

Amarillo Medical Specialists, Amarillo

Palm Research Center Inc-Vegas, Las Vegas

Desert Oasis Hlthcr Med Group, Palm Springs

Clinical Trials Research_Sacramento_0, Sacramento